• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重度慢性阻塞性肺疾病急性加重患者的死亡预测因素

Mortality Predictors in Patients with Severe COPD Exacerbation.

作者信息

Cojocaru Elena, Haliga Raluca Ecaterina, Ene Gianina-Valentina Băcescu, Cojocaru Cristian

机构信息

Morpho-Functional Sciences II Department, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iași, Romania.

Medical III Department, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iași, Romania.

出版信息

J Clin Med. 2025 Apr 27;14(9):3028. doi: 10.3390/jcm14093028.

DOI:10.3390/jcm14093028
PMID:40364060
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12072224/
Abstract

Severe acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are a leading cause of intensive care unit (ICU) admissions and in-hospital mortality. Several hematological inflammatory biomarkers, including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), derived NLR (dNLR), and systemic immune-inflammation index (SII), have been proposed as markers of disease severity and mortality. A retrospective study was conducted on 104 ICU patients with AECOPD over a two-year period. We collected and analyzed clinical, demographic, and laboratory data. The hematological indices of the two groups-survivors (n = 39) and non-survivors (n = 65)-were compared to assess differences. We used t-tests, ANOVA, chi-square tests, and Mann-Whitney U tests to compare the groups. The factors that independently predicted mortality were identified using multivariate logistic regression. We examined survival differences using Kaplan-Meier analysis, and ROC curves were utilized to evaluate the predictive power of each biomarker. Mortality was substantially predicted by higher SII (OR: 1.92, 95% CI: 1.24-3.08, = 0.002) and NLR (OR: 2.89, 95% CI: 1.72-4.82, < 0.001). Patients with NLR > 8.0 and SII > 1800 had significantly lower survival rates (log-rank < 0.001), according to Kaplan-Meier analysis. SII (AUC = 0.79) and NLR (AUC = 0.82) were the best predictors of death, according to ROC analysis. In ICU-admitted AECOPD patients, NLR, MLR, PLR, dNLR, and SII are independent predictors of mortality. Due to their ease of evaluation and predictive capabilities, they should be included in ICU risk models for early interventions.

摘要

慢性阻塞性肺疾病严重急性加重(AECOPD)是重症监护病房(ICU)收治和院内死亡的主要原因。包括中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)、单核细胞与淋巴细胞比值(MLR)、衍生NLR(dNLR)和全身免疫炎症指数(SII)在内的几种血液学炎症生物标志物已被提议作为疾病严重程度和死亡率的标志物。对104例AECOPD的ICU患者进行了为期两年的回顾性研究。我们收集并分析了临床、人口统计学和实验室数据。比较了两组(幸存者,n = 39;非幸存者,n = 65)的血液学指标以评估差异。我们使用t检验、方差分析、卡方检验和曼-惠特尼U检验来比较各组。使用多因素逻辑回归确定独立预测死亡率的因素。我们使用Kaplan-Meier分析检查生存差异,并利用ROC曲线评估每个生物标志物的预测能力。较高的SII(OR:1.92,95%CI:1.24 - 3.08,P = 0.002)和NLR(OR:2.89,95%CI:1.72 - 4.82,P < 0.001)可显著预测死亡率。根据Kaplan-Meier分析,NLR > 8.0且SII > 1800的患者生存率显著较低(对数秩检验P < 0.001)。根据ROC分析,SII(AUC = 0.79)和NLR(AUC = 0.82)是死亡的最佳预测指标。在入住ICU的AECOPD患者中,NLR、MLR、PLR、dNLR和SII是死亡率的独立预测指标。由于它们易于评估且具有预测能力,应将它们纳入ICU风险模型以进行早期干预。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01a2/12072224/1e254edc1d18/jcm-14-03028-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01a2/12072224/e43a1eba6a70/jcm-14-03028-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01a2/12072224/24f373a29565/jcm-14-03028-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01a2/12072224/35ecdf5638ba/jcm-14-03028-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01a2/12072224/0d312d6d6fea/jcm-14-03028-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01a2/12072224/aa0b9dc03c81/jcm-14-03028-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01a2/12072224/f0d4923aae35/jcm-14-03028-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01a2/12072224/1e254edc1d18/jcm-14-03028-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01a2/12072224/e43a1eba6a70/jcm-14-03028-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01a2/12072224/24f373a29565/jcm-14-03028-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01a2/12072224/35ecdf5638ba/jcm-14-03028-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01a2/12072224/0d312d6d6fea/jcm-14-03028-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01a2/12072224/aa0b9dc03c81/jcm-14-03028-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01a2/12072224/f0d4923aae35/jcm-14-03028-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01a2/12072224/1e254edc1d18/jcm-14-03028-g007.jpg

相似文献

1
Mortality Predictors in Patients with Severe COPD Exacerbation.重度慢性阻塞性肺疾病急性加重患者的死亡预测因素
J Clin Med. 2025 Apr 27;14(9):3028. doi: 10.3390/jcm14093028.
2
The clinical value of the neutrophil-to-lymphocyte ratio, systemic immune-inflammation index, monocyte-to-lymphocyte ratio and platelet-to-lymphocyte ratio for predicting the severity of patients with autoimmune encephalitis.中性粒细胞与淋巴细胞比值、全身免疫炎症指数、单核细胞与淋巴细胞比值及血小板与淋巴细胞比值对预测自身免疫性脑炎患者病情严重程度的临床价值。
Front Neurol. 2025 Feb 28;16:1498007. doi: 10.3389/fneur.2025.1498007. eCollection 2025.
3
Inflammatory markers as predictors of in-hospital mortality in acute exacerbation of chronic obstructive pulmonary disease (AECOPD) patients with acute respiratory failure: insights from the MIMIC-IV database.炎症标志物作为慢性阻塞性肺疾病急性加重(AECOPD)合并急性呼吸衰竭患者院内死亡的预测指标:来自MIMIC-IV数据库的见解
J Thorac Dis. 2024 Dec 31;16(12):8250-8261. doi: 10.21037/jtd-24-1287. Epub 2024 Dec 16.
4
Platelet-to-Lymphocyte Ratio (PLR), Neutrophil-to-Lymphocyte Ratio (NLR), Monocyte-to-Lymphocyte Ratio (MLR), and Eosinophil-to-Lymphocyte Ratio (ELR) as Biomarkers in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD).血小板与淋巴细胞比值(PLR)、中性粒细胞与淋巴细胞比值(NLR)、单核细胞与淋巴细胞比值(MLR)和嗜酸性粒细胞与淋巴细胞比值(ELR)作为慢性阻塞性肺疾病急性加重(AECOPD)患者的生物标志物。
Int J Chron Obstruct Pulmon Dis. 2024 Feb 23;19:501-518. doi: 10.2147/COPD.S447519. eCollection 2024.
5
[Predictive value of whole blood cell derived inflammatory markers in combination with NT-proBNP on the prognosis of patients with chronic heart failure].全血细胞衍生炎症标志物联合NT-proBNP对慢性心力衰竭患者预后的预测价值
Zhonghua Xin Xue Guan Bing Za Zhi. 2025 Feb 24;53(2):143-150. doi: 10.3760/cma.j.cn112148-20241211-00774.
6
Systemic Immune-Inflammation Index Is Associated with Adverse Outcomes in Patients Hospitalized for AECOPD: A Multicenter Cohort Study.全身免疫炎症指数与慢性阻塞性肺疾病急性加重期住院患者的不良预后相关:一项多中心队列研究。
Respiration. 2025 Apr 15:1-19. doi: 10.1159/000545267.
7
Biomarkers (NLR, PLR, SII) for Frequent COPD Exacerbations: Diagnostic and Clinical Management Implications in a Retrospective Study.慢性阻塞性肺疾病频繁急性加重的生物标志物(中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值、全身免疫炎症指数):一项回顾性研究中的诊断及临床管理意义
Int J Chron Obstruct Pulmon Dis. 2025 Apr 5;20:987-998. doi: 10.2147/COPD.S510118. eCollection 2025.
8
Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Monocyte-to-Lymphocyte Ratio (MLR) as Biomarkers in Diagnosis Evaluation of Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective, Observational Study.中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)及单核细胞与淋巴细胞比值(MLR)作为慢性阻塞性肺疾病急性加重诊断评估的生物标志物:一项回顾性观察研究
Int J Chron Obstruct Pulmon Dis. 2024 Apr 15;19:933-943. doi: 10.2147/COPD.S452444. eCollection 2024.
9
Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值对慢性阻塞性肺疾病急性加重患者院内死亡率的预后作用
Int J Chron Obstruct Pulmon Dis. 2017 Aug 3;12:2285-2290. doi: 10.2147/COPD.S141760. eCollection 2017.
10
Are Neutrophil-Lymphocyte, Platelet-Lymphocyte, and Monocyte-Lymphocyte Ratios Prognostic Indicators in Patients With Chronic Obstructive Pulmonary Disease in Intensive Care Units?中性粒细胞与淋巴细胞、血小板与淋巴细胞以及单核细胞与淋巴细胞比值是重症监护病房中慢性阻塞性肺疾病患者的预后指标吗?
Cureus. 2022 Mar 26;14(3):e23499. doi: 10.7759/cureus.23499. eCollection 2022 Mar.

本文引用的文献

1
The neutrophil-lymphocyte ratio predicts all-cause and cardiovascular mortality among United States adults with COPD: results from NHANES 1999-2018.中性粒细胞与淋巴细胞比值可预测美国慢性阻塞性肺疾病(COPD)成人患者的全因死亡率和心血管死亡率:1999 - 2018年美国国家健康与营养检查调查(NHANES)结果
Front Med (Lausanne). 2024 Sep 25;11:1443749. doi: 10.3389/fmed.2024.1443749. eCollection 2024.
2
The Biomarker Potential of the Neutrophil-to-Lymphocyte Ratio in Acute Exacerbation of Chronic Obstructive Pulmonary Disease.中性粒细胞与淋巴细胞比值在慢性阻塞性肺疾病急性加重期的生物标志物潜力
Cureus. 2024 Aug 13;16(8):e66750. doi: 10.7759/cureus.66750. eCollection 2024 Aug.
3
Association between systemic inflammatory markers and chronic obstructive pulmonary disease: A population-based study.
全身炎症标志物与慢性阻塞性肺疾病之间的关联:一项基于人群的研究。
Heliyon. 2024 May 18;10(10):e31524. doi: 10.1016/j.heliyon.2024.e31524. eCollection 2024 May 30.
4
Diagnostic insights from chemometric analysis of hemogram inflammatory indexes in male smokers with and without asthma or chronic obstructive pulmonary disease.基于血象炎症指标的化学计量学分析对男性吸烟人群中哮喘、COPD 及非哮喘、COPD 患者的诊断意义
Int J Lab Hematol. 2024 Aug;46(4):627-636. doi: 10.1111/ijlh.14264. Epub 2024 Mar 15.
5
Predictive role of neutrophil-percentage-to-albumin, neutrophil-to-lymphocyte and eosinophil-to-lymphocyte ratios for mortality in patients with COPD: Evidence from NHANES 2011-2018.中性粒细胞百分比与白蛋白、中性粒细胞与淋巴细胞和嗜酸性粒细胞与淋巴细胞比值对 COPD 患者死亡率的预测作用:来自 NHANES 2011-2018 的证据。
Respirology. 2023 Dec;28(12):1136-1146. doi: 10.1111/resp.14589. Epub 2023 Sep 1.
6
Association of Blood Inflammatory Biomarkers with Clinical Outcomes in Patients with AECOPD: An 8-Year Retrospective Study in Beijing.血液炎症生物标志物与 AECOPD 患者临床结局的相关性:北京一项 8 年回顾性研究。
Int J Chron Obstruct Pulmon Dis. 2023 Aug 17;18:1783-1802. doi: 10.2147/COPD.S416869. eCollection 2023.
7
COPD Exacerbation: Why It Is Important to Avoid ICU Admission.慢性阻塞性肺疾病急性加重:为何避免入住重症监护病房很重要。
J Clin Med. 2023 May 9;12(10):3369. doi: 10.3390/jcm12103369.
8
D-Dimer and Procalcitonin Improve the Sensitivity of BAP-65 Score in Predicting AECOPD Patients Admission to ICU.D-二聚体和降钙素原可提高 BAP-65 评分对 AECOPD 患者 ICU 住院的预测敏感性。
Clin Lab. 2023 Feb 1;69(2). doi: 10.7754/Clin.Lab.2022.220343.
9
Clinical significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute exacerbations of COPD: present and future.中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值在 COPD 急性加重期的临床意义:现状与未来。
Eur Respir Rev. 2022 Nov 2;31(166). doi: 10.1183/16000617.0095-2022. Print 2022 Dec 31.
10
Etiology of Emergency Visit and In-Hospital Outcomes of Patients with COPD.慢性阻塞性肺疾病患者急诊就诊病因及住院结局
Emerg Med Int. 2022 Aug 29;2022:8247133. doi: 10.1155/2022/8247133. eCollection 2022.